Written By: BrightFocus Editorial Staff
(CLARKSBURG, MD)– BrightFocus Foundation, a nonprofit organization funding scientific research to end diseases of mind and sight, Alzheimer’s, macular degeneration and glaucoma, announced a special program, Brain Info Live: A Fireside Chat for Caregivers with Richard Lui on Monday, December 6.
Lui, a MSNBC news anchor, author, and filmmaker, will discuss his experience caring for his father with Alzheimer’s and glaucoma with Maddy Dychtwald, Age Wave co-founder and BrightFocus board member. Lui will talk about his new book, Enough About Me: The Unexpected Power of Selflessness and share caregiving tips. His recent documentary Sky Blossom spotlights young caregivers quietly growing up as America’s next greatest generation.
Brain Info Live: A Fireside Chat for Caregivers with Richard Lui will be streamed live on the BrightFocus website and via the BrightFocus Facebook page on December 6, 3 pm ET/noon PT.
BrightFocus Foundation is a leading private funder of research to treat and cure Alzheimer’s, macular degeneration, and glaucoma, currently supporting a portfolio of over 260 projects around the globe, a $65 million investment.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus Foundation received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants.
Report shows that boosting research investment into the wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years.
Another disease-modifying Alzheimer's therapy hits the market.
An FDA decision on Eli Lilly's donanemab is expected in the coming months.
